Sorted by: Date Source

SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial

In SeekingAlpha ETFs - Posted 13 weeks ago

Beijing SL Pharmaceutical Co. Ltd. (SZSE: 002038) received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin ...

Tags: beijing china clinical trial pharma szse

SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial

In SeekingAlpha China Stocks - Posted 13 weeks ago

Beijing SL Pharmaceutical Co. Ltd. (SZSE: 002038) received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin ...

Tags: beijing china szse

Featured Investment Blogs

24/7 Wall St.
Insightful Analysis and Commentary for U.S. and Global Equity Investors...

Dealscape
...

Environmental Economics
Economists on Environmental and Natural Resources: News, Opinion, and Analysis...

Paul Kedrosky's Infectious Greed
Musing about technology, finance, venture capital, & the money culture with Paul Kedrosky...

Jeff Matthews Is Not Making This Up
The World of Wall Street in all its glory, and anything else that strikes our fancy. Informed observations about comp...

Stock Market Beat
Our beat is the stock market. Our job is to beat it....

TechCrunch
TechCrunch profiles the companies, products and events that are defining and transforming the new web. TechCrunch is ...

Trader Mike
Stock market commentary & trading ideas. Stock market weblog (blog), swing trading, day trading, stock picks, techni...

More Blogs